PER
Click for more information
6.90% 8.1¢ percheron therapeutics limited

Where others have failed will Atl1102 succeed ?, page-991

  1. Uboy
    4,683 Posts.
    lightbulb Created with Sketch. 1086
    clock Created with Sketch.
    25/10/21
    14:06
    Post #: 57049535
    Easy....

    Don't sell.

    This time next year ANP will have 3 or 4 Phase 2B trials going concurrently with Big Pharma.

    First in class - Best in class.

    The only Biotech globally focusing on CD49d.
    .
    ANP Price at posting: 34.5¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 30  Upvote
    lightbulb Created with Sketch. 3  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

MYR Myer lobs proposed merger at major shareholder Premier Investments
right-arrow Created with Sketch.
WAF West African Resources draws final US$100M from Sprott-backed loan for gold plant
right-arrow Created with Sketch.
NEWS Money and Investing: Talking the minefield of divorce & family law
right-arrow Created with Sketch.
NEWS From the Floor: Perth conference highlights
right-arrow Created with Sketch.
AML Cultural heritage agreement puts Walford Creek exploration back on the map
right-arrow Created with Sketch.
IMU Imugene doses first cancer patient in Oasis trial
right-arrow Created with Sketch.
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.1¢ 		Change
-0.006(6.90%) 		Mkt cap ! $73.02M
Open High Low Value Volume
8.7¢ 8.7¢ 8.1¢ $154.2K 1.820M

Buyers (Bids)

No. Vol. Price($)
2 33824 8.1¢
 

Sellers (Offers)

Price($) Vol. No.
8.4¢ 275242 2
View Market Depth
Last trade - 16.10pm 24/06/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.